SDS Biotech K.K. announced consolidated financial results for the nine months ended December 31, 2019. For the period, the company reported net sales of JPY 8,262 million against JPY 8,177 million for the same period a year ago. Operating income was JPY 427 million against JPY 694 million for the same period a year ago. Net income was JPY 776 million against JPY 274 million for the same period a year ago. Net income per share was JPY 99.15 per share against JPY 35.00 per share for the same period a year ago.

For the year ending March 31, 2020, the company expects net sales to be JPY 13,550 million, operating income to be JPY 1,110 million, net income to be JPY 1,110 million, and earnings per share to be JPY 141.74 per share.